A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways

Baojin Wang(University of Tennessee Health Science Center), Junming Yue(University of Tennessee Health Science Center)

Journal of Cancer

January 1, 2021

10.7150/jca.61066

Cited by 6

Related Papers

Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells

|Journal of Cancer|2016|109

Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells

|Oncology Letters|2018|23